BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Breaking Barriers Past: Celebrating the Legacy of Dr. Clarice Reid, Pioneer in Sickle Cell Research
Form 7 Monthly Progress Report February 1 2023 Name of Listed Issuer: Trading Symbol: Number
Form 7 Monthly Progress Report November 1 2022 Name of Listed Issuer: Trading Symbol: Number
Form 7 Monthly Progress Report November 1, 2022 Name of Listed Issuer: Trading Symbol: Number
Form 7 Monthly Progress Report November 1, 2022 Name of Listed Issuer: Trading Symbol: Number
Form 7 Monthly Progress Report – August 2022 Name of Listed Issuer: Trading Symbol: Number
Form 7 Monthly Progress Report – August 2022 Name of Listed Issuer: Trading Symbol: Number
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol:
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol:
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]